Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The study aims to assess and analyze some selected antioxidants and laboratory parameters during hospitalization of the patients with acute pancreatitis. It will allow to better understanding of the mechanisms of disease and the development of better diagnostic, treatment and monitoring.
It is an observational diagnostic study and does not involve any additional administration of medicinal substances, modification of treatment or dropping the use of routine methods of treatment of a disease. The study procedure includes detailed personal medical history as separate document like as a routine medical interview, and three times taking a small amount of venous blood (together about 15 ml), in the first, third, and seventh day of hospitalization (in the case of longer hospital treatment).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 | Control group non-exposed to tobacco smoking | ||
| 2 | Control group exposed to tobacco smoking | ||
| 3 | Patients with acute pancreatitis non-exposed to tobacco smoking | ||
| 4 | Patients with acute pancreatitis exposed to tobacco smoking |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Pro-inflammatory effect of tobacco smoke exposure measured by hsCRP concentration in the blood of patients with acute pancreatitis | 3 weeks | |
| Pro-inflammatory effect of tobacco smoke exposure measured by Interleukin-6 concentration in the blood of patients with acute pancreatitis | 2 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| The estimation of antioxidant status measured by the activities of antioxidant enzymes in the blood | 12 months | |
| The estimation of antioxidant status measured by small molecular antioxidants concentration in the blood | 3 months |
| Measure | Description | Time Frame |
|---|---|---|
| The estimation of the concentration of vascular endothelium damage marker (endothelin) in the blood | 3 months | |
| The estimation of the concentration of total cholesterol in the blood | 3 weeks | |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Halina Milnerowicz, Prof. | Wroclaw Medical University, Wroclaw, Poland | Study Chair |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010195 | Pancreatitis |
| ID | Term |
|---|---|
| D010182 | Pancreatic Diseases |
| D004066 | Digestive System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
The blood samples taking into tubes containing heparin, EDTA and serum clotting activator to obtain plasma, erythrocyte lysate and serum.
| The estimation of prooxidant status measured by the concentration of lipids peroxidation products in the blood | 2 months |
| The estimation of prooxidant status measured by the concentration of advanced oxidation protein products in the blood | 1 months |
| The estimation of the concentration of triglycerides in the blood |
| 3 weeks |
| The estimation of the concentration of low-density lipoprotein (LDL) in the blood | 3 months |
| The estimation of the concentration of high-density lipoprotein (HDL) in the blood | 3 weeks |
| The estimation of endocrine functions of pancreas measured by the concentration of insulin in the blood | 2 months |
| The estimation of endocrine functions of pancreas measured by the concentration of glucagon in the blood | 1 month |
| The estimation of endocrine functions of pancreas measured by the concentration of pancreatic polypeptide in the blood | 1 month |
| The estimation of endocrine functions of pancreas measured by the concentration of somatostatin in the blood | 1 month |
| The estimation of endocrine functions of pancreas measured by the concentration of ghrelin in the blood | 2 weeks |
| The estimation of exocrine functions of pancreas measured by the activity of amylase and lipase in the blood | 3 months |